{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:56:43Z","timestamp":1790553403820,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["USAID - 72064123CA0007"],"award-info":[{"award-number":["USAID - 72064123CA0007"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004417","name":"Global Fund to Fight AIDS, Tuberculosis and Malaria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004417","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-026-06003-x","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:08:15Z","timestamp":1783069695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of artemether-lumefantrine combination for the treatment of uncomplicated Plasmodium falciparum malaria after 16\u00a0years of its introduction into Ghana\u2019s antimalarial medicines policy"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1840-6979","authenticated-orcid":false,"given":"Benjamin","family":"Abuaku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Boateng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Odurowah","family":"Duah-Quashie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana Yaw","family":"Peprah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Asamoah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sena Adzoa","family":"Matrevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Idun-Acquah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice Obeng","family":"Amoako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Baafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Gyekye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Amankrah-Yeboah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Logonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selassie","family":"Bruku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwesi","family":"Tandoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neils","family":"Quashie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Owusu-Antwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwadwo Ansah","family":"Koram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Hilarius","family":"Abiwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keziah Laurencia","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"issue":"3","key":"6003_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.actatropica.2005.06.009","volume":"95","author":"TK Mutabingwa","year":"2005","unstructured":"Mutabingwa TK. Artemisinin-based combination therapies (ACTs): Best hope for malaria treatment but inaccessible to the needy! Acta Trop. 2005;95(3):305\u201315. https:\/\/doi.org\/10.1016\/j.actatropica.2005.06.009.","journal-title":"Acta Trop"},{"key":"6003_CR2","doi-asserted-by":"publisher","DOI":"10.2471\/B09514","volume-title":"WHO guidelines for malaria, 13 August 2025","author":"WHO","year":"2025","unstructured":"WHO. WHO guidelines for malaria, 13 August 2025. Geneva: World Health Organization; 2025. https:\/\/doi.org\/10.2471\/B09514."},{"key":"6003_CR3","volume-title":"Strategy to respond to antimalarial drug resistance in Africa","author":"WHO","year":"2022","unstructured":"WHO. Strategy to respond to antimalarial drug resistance in Africa. Geneva: World Health Organization; 2022."},{"key":"6003_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-04923-0","volume":"23","author":"B Ngasala","year":"2024","unstructured":"Ngasala B, Bushukatale S, Chiduo M, Makene T, Mkony L, Mohamed A, et al. Efficacy of artesunate-amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in mainland Tanzania. Malar J. 2024;23:90. https:\/\/doi.org\/10.1186\/s12936-024-04923-0.","journal-title":"Malar J"},{"key":"6003_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaf155","author":"C Fan\u00e7ony","year":"2025","unstructured":"Fan\u00e7ony C, Fortes-Gabriel E, Zage F, Alexiou E, Broumou I, Pernaute-Lau L, et al. Artemether-lumefantrine treatment selects Plasmodium falciparum Multidrug resistance 1 (pfmdr 1) increased copy number among African malaria infections. J Infect Dis. 2025. https:\/\/doi.org\/10.1093\/infdis\/jiaf155.","journal-title":"J Infect Dis"},{"issue":"2","key":"6003_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116856","volume":"10","author":"S Chatio","year":"2015","unstructured":"Chatio S, Aborigo R, Adongo BP, Anyorigiya T, Akweongo P, Oduro A. Adherence and uptake of artemisinin-based combination treatments for uncomplicated malaria: a qualitative study in Northern Ghana. PLoS ONE. 2015;10(2):e0116856. https:\/\/doi.org\/10.1371\/journal.pone.0116856.","journal-title":"PLoS ONE"},{"key":"6003_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijpddr.2021.05.007","volume":"16","author":"AF Siddiqui","year":"2021","unstructured":"Siddiqui AF, Liang X, Cui L. Plasmodium falciparum resistance to ACTs: emergence, mechanisms, and outlook. Int J Parasitol Drugs Drug Resist. 2021;16:102\u201318. https:\/\/doi.org\/10.1016\/j.ijpddr.2021.05.007.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"3","key":"6003_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11908-010-0099-y","volume":"12","author":"TJ Lin","year":"2010","unstructured":"Lin TJ, Juliano JJ, Wongsrichanalai C. Drug-resistant malaria: the era of ACT. Curr Infect Dis Rep. 2010;12(3):165\u201373. https:\/\/doi.org\/10.1007\/s11908-010-0099-y.","journal-title":"Curr Infect Dis Rep"},{"issue":"1","key":"6003_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/tropicalmed4010026","volume":"4","author":"C Nsanzabana","year":"2019","unstructured":"Nsanzabana C. Resistance to artemisinin combination therapies (ACTs): do not forget the partner drug! trop. Med Infect Dis. 2019;4(1):26. https:\/\/doi.org\/10.3390\/tropicalmed4010026.","journal-title":"Med Infect Dis"},{"issue":"5","key":"6003_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jpha.2020.07.005","volume":"11","author":"N Erhunse","year":"2021","unstructured":"Erhunse N, Sahal D. Protecting future antimalarials from the trap of resistance: Lessons from artemisinin-based combination therapy (ACT) failures. J Pharm Anal. 2021;11(5):541\u201354. https:\/\/doi.org\/10.1016\/j.jpha.2020.07.005.","journal-title":"J Pharm Anal"},{"key":"6003_CR11","volume-title":"Global technical strategy for malaria 2016\u20132030, 2021 update","author":"WHO","year":"2021","unstructured":"WHO. Global technical strategy for malaria 2016\u20132030, 2021 update. Geneva: World Health Organization; 2021."},{"issue":"5","key":"6003_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361(5):455\u201367. https:\/\/doi.org\/10.1056\/NEJMoa0808859.","journal-title":"N Engl J Med"},{"issue":"3","key":"6003_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1473-3099(18)30068-9","volume":"18","author":"R Amato","year":"2018","unstructured":"Amato R, Pearson RD, Almagro-Garcia J, Amaratunga C, Lim P, Suon S, et al. Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study. Lancet Infect Dis. 2018;18(3):337\u201345. https:\/\/doi.org\/10.1016\/S1473-3099(18)30068-9.","journal-title":"Lancet Infect Dis"},{"key":"6003_CR14","volume-title":"World malaria report 2024: addressing inequality in the global malaria response","author":"WHO","year":"2024","unstructured":"WHO. World malaria report 2024: addressing inequality in the global malaria response. Geneva: World Health Organization; 2024."},{"issue":"3","key":"6003_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.actatropica.2005.06.018","volume":"95","author":"KA Koram","year":"2005","unstructured":"Koram KA, Abuaku B, Duah N, Quashie N. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. Acta Trop. 2005;95(3):194\u2013203. https:\/\/doi.org\/10.1016\/j.actatropica.2005.06.018.","journal-title":"Acta Trop"},{"key":"6003_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-388","volume":"11","author":"B Abuaku","year":"2012","unstructured":"Abuaku B, Duah N, Quaye L, Quashie N, Koram K. Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana. Malar J. 2012;11:388. https:\/\/doi.org\/10.1186\/1475-2875-11-388.","journal-title":"Malar J"},{"key":"6003_CR17","volume-title":"Antimalarial medicines policy, Ghana, September 2022","author":"MOH","year":"2022","unstructured":"MOH. Antimalarial medicines policy, Ghana, September 2022. Accra: Ministry of Health; 2022."},{"key":"6003_CR18","volume-title":"Methods for surveillance of antimalarial drug efficacy","author":"WHO","year":"2009","unstructured":"WHO. Methods for surveillance of antimalarial drug efficacy. Geneva: World Health Organization; 2009."},{"key":"6003_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04182-x","volume":"21","author":"MM Plucinski","year":"2022","unstructured":"Plucinski MM, Ashley EA, Bassat Q, Venkatesan M, Rosenthal PJ, Halsey ES. STARTER checklist for antimalarial therapeutic efficacy reporting. Malar J. 2022;21:187. https:\/\/doi.org\/10.1186\/s12936-022-04182-x.","journal-title":"Malar J"},{"issue":"1","key":"6003_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06961-4","volume":"21","author":"B Abuaku","year":"2021","unstructured":"Abuaku B, Duah-Quashie NO, Quashie N, Gyasi A, Afriyie PO, Owusu-Antwi F, et al. Trends and predictive factors for treatment failure following artemisinin-based combination therapy among children with uncomplicated malaria in Ghana: 2005-2018. BMC Infect Dis. 2021;21(1):1255. https:\/\/doi.org\/10.1186\/s12879-021-06961-4.","journal-title":"BMC Infect Dis"},{"key":"6003_CR21","volume-title":"National Malaria Elimination Strategic Plan (NMESP) of Ghana: 2024\u20132028","author":"MOH","year":"2023","unstructured":"MOH. National Malaria Elimination Strategic Plan (NMESP) of Ghana: 2024\u20132028. Accra: Ministry of Health; 2023."},{"key":"6003_CR22","volume-title":"Malaria case management pocket manual: National Malaria Elimination Program (NMEP)","author":"MOH","year":"2023","unstructured":"MOH. Malaria case management pocket manual: National Malaria Elimination Program (NMEP). Accra: Ministry of Health; 2023."},{"key":"6003_CR23","unstructured":"WHO Malaria Parasite Counting. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/433b7866-daa5-45e9-8de3-953c321fbc58\/content. Accessed 10 Oct 2025."},{"key":"6003_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-8-78","volume":"8","author":"A Liljander","year":"2009","unstructured":"Liljander A, Wiklund L, Falk N, Kweku M, M\u00e5rtensson A, Felger I, et al. Optimization and validation of multi-coloured capillary electrophoresis for genotyping of Plasmodium falciparum merozoites surface proteins (msp1 and 2). Malar J. 2009;8:78. https:\/\/doi.org\/10.1186\/1475-2875-8-78.","journal-title":"Malar J"},{"issue":"1826","key":"6003_CR25","doi-asserted-by":"publisher","first-page":"20153038","DOI":"10.1098\/rspb.2015.3038","volume":"283","author":"M Bushman","year":"1826","unstructured":"Bushman M, Morton L, Duah N, Quashie N, Abuaku B, Koram KA, et al. Within-host competition and drug resistance in the human malaria parasite Plasmodium falciparum. Proc Biol Sci. 1826;283(1826):20153038. https:\/\/doi.org\/10.1098\/rspb.2015.3038.","journal-title":"Proc Biol Sci"},{"key":"6003_CR26","volume-title":"Informal consultation on methodology to distinguish reinfection from recrudescence in high malaria transmission areas: Report of a virtual meeting, 17\u201318 May 2021","author":"WHO","year":"2021","unstructured":"WHO. Informal consultation on methodology to distinguish reinfection from recrudescence in high malaria transmission areas: Report of a virtual meeting, 17\u201318 May 2021. Geneva: World Health Organization; 2021."},{"key":"6003_CR27","unstructured":"WHO data entry and analysis tool. https:\/\/who.int\/teams\/global-malaria-programme\/case-management\/drug-efficacy-and-resistance\/tools-for-monitoring-antimalarial-drug-efficacy. Accessed 24 Jan 2025"},{"key":"6003_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.108084","volume":"161","author":"O Awodele","year":"2025","unstructured":"Awodele O, Bello IS, Akodu BA, Ahmed AA, Usman S, Bolarinwa RA, et al. Arterolane and piperaquine Vs. artemether and lumefantrine in uncomplicated malaria: a randomized study in Nigeria. Int J Infect Dis. 2025;161:108084. https:\/\/doi.org\/10.1016\/j.ijid.2025.108084.","journal-title":"Int J Infect Dis"},{"key":"6003_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-05088-6","volume":"23","author":"KM Oyebola","year":"2024","unstructured":"Oyebola KM, Ligali FC, Owoloye AJ, Aina OO, Alo YM, Erinwusi B, et al. Assessing the therapeutic efficacy of artemether-lumefantrine for uncomplicated malaria in Lagos, Nigeria: a comprehensive study on treatment response and resistance markers. Malar J. 2024;23:261. https:\/\/doi.org\/10.1186\/s12936-024-05088-6.","journal-title":"Malar J"},{"key":"6003_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-04922-1","volume":"23","author":"AM Dorkenoo","year":"2024","unstructured":"Dorkenoo AM, Warsame M, Ataba E, Hemou M, Yakpa K, Sossou E, et al. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021. Malar J. 2024;23:92. https:\/\/doi.org\/10.1186\/s12936-024-04922-1.","journal-title":"Malar J"},{"key":"6003_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-025-05576-3","volume":"24","author":"VS Koko","year":"2025","unstructured":"Koko VS, Skrip L, Kumeh O, Washington T, Diallo MO, Kafuko J, et al. Efficacy and safety of artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated Plasmodium falciparum malaria in Liberia, 2022-2023. Malar J. 2025;24:319. https:\/\/doi.org\/10.1186\/s12936-025-05576-3.","journal-title":"Malar J"},{"issue":"3","key":"6003_CR32","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1684\/abc.2025.1973","volume":"83","author":"I Yacouba","year":"2025","unstructured":"Yacouba I, Issa I, Sanoussi MK, Jika M, Hamani BS, Diallo O, et al. Therapeutic effectiveness and safety of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 5 to 15 years in three epidemiological strata of malaria in Niger [Article in French]. Ann Biol Clin. 2025;83(3):280\u201392. https:\/\/doi.org\/10.1684\/abc.2025.1973.","journal-title":"Ann Biol Clin"},{"key":"6003_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12936-024-04945-8","volume":"23","author":"IM Laminou","year":"2024","unstructured":"Laminou IM, Issa I, Adehossi E, Maman K, Jackou H, Coulibaly E, et al. Therapeutic efficacy and tolerability of artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Niger, 2020. Malar J. 2024;23:144. https:\/\/doi.org\/10.1186\/s12936-024-04945-8.","journal-title":"Malar J"},{"key":"6003_CR34","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s12936-025-05679-x","volume":"24","author":"IM Laminou","year":"2025","unstructured":"Laminou IM, Kabirou SM, Arzika II, Yahaya A, Ahmed J, Deme AB, et al. Therapeutic efficacy of artemether-lumefantrine and molecular markers of antimalarial resistance in Niger, 2022. Malar J. 2025;24:448. https:\/\/doi.org\/10.1186\/s12936-025-05679-x.","journal-title":"Malar J"},{"key":"6003_CR35","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12936-024-05087-7","volume":"23","author":"D Daka","year":"2024","unstructured":"Daka D, Woldeyes D, Golassa L, Alemayehu GS, Zewde Z, Tamiru G, et al. Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Arba Minch Zuria District, Gamo Zone. Southwest Ethiopia Malar J. 2024;23:282. https:\/\/doi.org\/10.1186\/s12936-024-05087-7.","journal-title":"Southwest Ethiopia Malar J"},{"key":"6003_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2025.107800","volume":"270","author":"T Kumsa","year":"2025","unstructured":"Kumsa T, Jima B, Tamiru G, Getu R, Melaku M, Tesfaye Y, et al. Efficacy and gametocyte carriage in Plasmodium falciparum cases treated with artemether-lumefantrine alone versus with single-dose primaquine in Ethiopia: a randomized controlled study. Acta Trop. 2025;270:107800. https:\/\/doi.org\/10.1016\/j.actatropica.2025.107800.","journal-title":"Acta Trop"},{"key":"6003_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12936-022-04436-8","volume":"22","author":"K Gubae","year":"2023","unstructured":"Gubae K, Mohammed H, Sime H, Hailgiorgis H, Mare AK, Gidey B, et al. Safety and therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria at Shecha health centre, Arba Minch. Ethiopia Malar J. 2023;22:9. https:\/\/doi.org\/10.1186\/s12936-022-04436-8.","journal-title":"Ethiopia Malar J"},{"key":"6003_CR38","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12936-024-05082-y","volume":"23","author":"D Woldesenbet","year":"2024","unstructured":"Woldesenbet D, Birhanie M, Abere A, Zeleke AJ, Bezabih MK, Semaw M, et al. Therapeutic efficacy and safety of artemether-lumefantrine combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria at Teda Health Centre, Northwest Ethiopia, 2022\/23. Malar J. 2024;23:266. https:\/\/doi.org\/10.1186\/s12936-024-05082-y.","journal-title":"Malar J"},{"key":"6003_CR39","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12936-025-05473-9","volume":"24","author":"A Nhama","year":"2025","unstructured":"Nhama A, Chidimatembue A, Nhamussua L, Bassat Q, da Silva C, Nhacolo A, et al. Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022. Malar J. 2025;24:231. https:\/\/doi.org\/10.1186\/s12936-025-05473-9.","journal-title":"Malar J"},{"key":"6003_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12936-025-05693-z","volume":"25","author":"A Gansane","year":"2026","unstructured":"Gansane A, Tarama C, Lingani M, Debe S, Tiendrebeogo F, Kinda R, et al. Efficacy of artemether-lumefantrine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso, 2020\u20132021. Malar J. 2026;25:10. https:\/\/doi.org\/10.1186\/s12936-025-05693-z.","journal-title":"Malar J"},{"key":"6003_CR41","doi-asserted-by":"publisher","first-page":"1715777","DOI":"10.3389\/fpubh.2025.1715777","volume":"13","author":"B Abuaku","year":"2026","unstructured":"Abuaku B, Boateng P, Peprah NY, Asamoah A, Duah-Quashie NO, Matrevi SA, et al. Therapeutic efficacy of dihydroartemisinin-piperaquine and artesunate-pyronaridine combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Ghana, 2023. Front Public Health. 2026;13:1715777. https:\/\/doi.org\/10.3389\/fpubh.2025.1715777.","journal-title":"Front Public Health"},{"key":"6003_CR42","volume-title":"Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019)","author":"WHO","year":"2020","unstructured":"WHO. Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019). Geneva: World Health Organization; 2020."},{"key":"6003_CR43","volume-title":"Multiple first-line therapies as part of the response to antimalarial drug resistance: an implementation guide","author":"WHO","year":"2024","unstructured":"WHO. Multiple first-line therapies as part of the response to antimalarial drug resistance: an implementation guide. Geneva: World Health Organization; 2024."},{"key":"6003_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-2848-1","volume":"18","author":"B Abuaku","year":"2019","unstructured":"Abuaku B, Duah-Quashie NO, Quaye L, Matrevi SA, Quashie N, Gyasi A, et al. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015\u20132017. Malar J. 2019;18:206. https:\/\/doi.org\/10.1186\/s12936-019-2848-1.","journal-title":"Malar J"},{"issue":"4","key":"6003_CR45","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01525-23","volume":"68","author":"PR Dimbu","year":"2024","unstructured":"Dimbu PR, Labuda S, Ferreira CM, Caquece F, Andre K, Pembele G, et al. Therapeutic response to four artemisinin-based combination therapies in Angola, 2021. Antimicrob Agents Chemother. 2024;68(4):e01525-23. https:\/\/doi.org\/10.1128\/aac.01525-23.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"6003_CR46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/infdis\/jiae425","volume":"231","author":"JE Laury","year":"2022","unstructured":"Laury JE, Mugittu K, Kajeguka DC, Kamugisha E, Ishengoma DS, Mandara CI, et al. Efficacy and safety of artemether-lumefantrine against uncomplicated Falciparum malaria infections in Tanzania, 2022: a single-arm clinical trial. J Infect Dis. 2022;231(1):251\u20139. https:\/\/doi.org\/10.1093\/infdis\/jiae425.","journal-title":"J Infect Dis"},{"key":"6003_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-04930-1","volume":"23","author":"NE Thomford","year":"2024","unstructured":"Thomford NE, Kellermann T, Biney RP, Dixon C, Nyarko SB, Ateko RO, et al. Therapeutic efficacy of generic artemether-lumefantrine in the treatment of uncomplicated malaria in Ghana: assessing antimalarial efficacy amidst pharmacogenetic variations. Malar J. 2024;23:125. https:\/\/doi.org\/10.1186\/s12936-024-04930-1.","journal-title":"Malar J"},{"key":"6003_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-291","volume":"13","author":"M Makanga","year":"2014","unstructured":"Makanga M. A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission. Malar J. 2014;13:291. https:\/\/doi.org\/10.1186\/1475-2875-13-291.","journal-title":"Malar J"},{"issue":"7","key":"6003_CR49","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S2666-5247(24)00023-5","volume":"5","author":"A Mahamar","year":"2024","unstructured":"Mahamar A, Smit MJ, Sanogo K, Sinaba Y, Niambele SM, Sacko A, et al. Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomized clinical trial in Ouelessebougou. Mali Lancet Microbe. 2024;5(7):633\u201344. https:\/\/doi.org\/10.1016\/S2666-5247(24)00023-5.","journal-title":"Mali Lancet Microbe"},{"key":"6003_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2509-9","volume":"17","author":"NJ White","year":"2018","unstructured":"White NJ. Anaemia and malaria. Malar J. 2018;17:371. https:\/\/doi.org\/10.1186\/s12936-018-2509-9.","journal-title":"Malar J"},{"key":"6003_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-3015-4","volume":"18","author":"BR Adegbite","year":"2019","unstructured":"Adegbite BR, Edoa JR, Honkpehedji YJ, Zinsou FJ, Dejon-Agobe JC, Mbong-Ngwese M, et al. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambar\u00e9n\u00e9, Gabon: an open-label clinical trial. Malar J. 2019;18:424. https:\/\/doi.org\/10.1186\/s12936-019-3015-4.","journal-title":"Malar J"},{"issue":"6","key":"6003_CR52","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4269\/ajtmh.20-0852","volume":"103","author":"MM Ippolito","year":"2020","unstructured":"Ippolito MM, Pringle JC, Siame M, Katowa B, Aydemir O, Oluoch PO, et al. Therapeutic efficacy of artemether-lumefantrine for uncomplicated falciparum malaria in northern Zambia. Am J Trop Med Hyg. 2020;103(6):224\u20132232. https:\/\/doi.org\/10.4269\/ajtmh.20-0852.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"6003_CR53","doi-asserted-by":"publisher","first-page":"199","DOI":"10.22354\/in.v22i4.738","volume":"22","author":"A Tob\u00f3n-Casta\u00f1o","year":"2018","unstructured":"Tob\u00f3n-Casta\u00f1o A, Garc\u00e9s-Murillo L, R\u00edos-Orrego A, Montiel-Ramos J, Salas BDL, Mesa-Echeverry E, et al. Artemeter-Lumefantrine therapeutic efficacy, safety and plasma levels in patients with uncomplicated falciparum malaria from the Colombian Pacific regi\u00f3n. Infectio. 2018;22(4):199\u2013205. https:\/\/doi.org\/10.22354\/in.v22i4.738.","journal-title":"Infectio"},{"key":"6003_CR54","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12916-015-0456-7","volume":"13","author":"WorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK\/PD Study Group","year":"2015","unstructured":"WorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK\/PD Study Group. Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data. BMC Med. 2015;13:227. https:\/\/doi.org\/10.1186\/s12916-015-0456-7.","journal-title":"BMC Med"},{"key":"6003_CR55","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S1473-3099(19)30426-8","volume":"20","author":"I Felger","year":"2020","unstructured":"Felger I, Snounou G, Hastings I, Moerhrle JJ, Beck HP. PCR-correction strategies for malaria drug trials: updates and clarifications. Lancet Infect Dis. 2020;20:e20-25. https:\/\/doi.org\/10.1016\/S1473-3099(19)30426-8.","journal-title":"Lancet Infect Dis"},{"key":"6003_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(24)00153-8","volume":"5","author":"A Schnoz","year":"2024","unstructured":"Schnoz A, Beuret C, Concu M, Hosch S, Rutaihwa LK, Golumbeanu M, et al. Genotyping methods to distinguish Plasmodium falciparum recrudescence from new infection for the assessment of antimalarial drug efficacy: an observational, single-centre, comparison study. Lancet Microbe. 2024;5:100914. https:\/\/doi.org\/10.1016\/S2666-5247(24)00153-8.","journal-title":"Lancet Microbe"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-026-06003-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-06003-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-06003-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:52:51Z","timestamp":1790553171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-026-06003-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6003"],"URL":"https:\/\/doi.org\/10.1186\/s12936-026-06003-x","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board of the Noguchi Memorial Institute for Medical Research, University of Ghana (NMIMR-IRB CPN 087\/23-24), and the Ethics Review Committee of the Ghana Health Service (GHS-ERC: 025\/05\/24). The study was retrospectively registered under the Pan African Clinical Trial Registry with an identification number PACTR202502791855505. Prior to enrollment, parents\/guardians were informed of the objectives, methods, anticipated benefits and potential risks of the study to their children. They were given the opportunity to seek clarifications before signing the written informed consent form.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"339"}}